Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
12662 | 890 | 53.9 | 89% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
11 | 4 | NEUROSCIENCES//CLINICAL NEUROLOGY//NEUROL | 1112395 |
305 | 3 | NICOTINIC ACETYLCHOLINE RECEPTOR//BENZODIAZEPINES//NICOTINIC RECEPTORS | 40571 |
1265 | 2 | NICOTINE//NICOTINIC RECEPTORS//NICOTINIC ACETYLCHOLINE RECEPTOR | 8795 |
12662 | 1 | CHRNA7//ALPHA 7//ALPHA 7 NICOTINIC RECEPTOR | 890 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | CHRNA7 | authKW | 899852 | 4% | 66% | 40 |
2 | ALPHA 7 | authKW | 561321 | 5% | 38% | 43 |
3 | ALPHA 7 NICOTINIC RECEPTOR | authKW | 478687 | 4% | 36% | 39 |
4 | ALPHA 7 NICOTINIC ACETYLCHOLINE RECEPTOR | authKW | 396715 | 5% | 25% | 47 |
5 | GTS 21 | authKW | 386142 | 2% | 51% | 22 |
6 | ALPHA 7 NACHR | authKW | 323235 | 4% | 27% | 35 |
7 | PNU 120596 | authKW | 308765 | 1% | 75% | 12 |
8 | NICOTINIC RECEPTORS | authKW | 262187 | 12% | 7% | 107 |
9 | CHRFAM7A | authKW | 228713 | 1% | 67% | 10 |
10 | ALPHA7 NICOTINIC RECEPTOR | authKW | 190591 | 1% | 56% | 10 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Neurosciences | 5199 | 45% | 0% | 398 |
2 | Pharmacology & Pharmacy | 2875 | 34% | 0% | 304 |
3 | Psychiatry | 920 | 12% | 0% | 111 |
4 | Chemistry, Medicinal | 913 | 10% | 0% | 90 |
5 | Biochemistry & Molecular Biology | 133 | 15% | 0% | 130 |
6 | Genetics & Heredity | 100 | 6% | 0% | 52 |
7 | Clinical Neurology | 81 | 6% | 0% | 51 |
8 | Behavioral Sciences | 71 | 2% | 0% | 22 |
9 | Geriatrics & Gerontology | 61 | 2% | 0% | 15 |
10 | Chemistry, Organic | 55 | 5% | 0% | 47 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | PSYCHIAT C268 71 | 102924 | 0% | 100% | 3 |
2 | R47W | 72644 | 1% | 35% | 6 |
3 | TSU AGING | 68616 | 0% | 100% | 2 |
4 | CHEM SCI NEUROSCI DISCOVERY | 45743 | 0% | 67% | 2 |
5 | NEUROSCI DK | 45739 | 0% | 33% | 4 |
6 | NEUROTEC MOL NEUROPHARMACOL | 44107 | 0% | 43% | 3 |
7 | EXCELLENCE PL BIOL | 35401 | 1% | 13% | 8 |
8 | ANTI INFLAMMATORY SIGNALING | 34308 | 0% | 100% | 1 |
9 | ASSAYS ARRAYS RD | 34308 | 0% | 100% | 1 |
10 | CENT NERVOUS SYST NEUROL DIS | 34308 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | NEUROPHARMACOLOGY | 5819 | 4% | 0% | 40 |
2 | JOURNAL OF MOLECULAR NEUROSCIENCE | 2454 | 2% | 1% | 14 |
3 | SLAS DISCOVERY | 1632 | 0% | 5% | 1 |
4 | BIOCHEMICAL PHARMACOLOGY | 1415 | 3% | 0% | 28 |
5 | NEUROPSYCHOPHARMACOLOGY | 1303 | 2% | 0% | 14 |
6 | ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES | 1246 | 1% | 1% | 5 |
7 | MOLECULAR PHARMACOLOGY | 1240 | 2% | 0% | 19 |
8 | JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS | 1236 | 3% | 0% | 28 |
9 | BRAIN CELL BIOLOGY | 978 | 0% | 3% | 1 |
10 | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 952 | 3% | 0% | 27 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CHRNA7 | 899852 | 4% | 66% | 40 | Search CHRNA7 | Search CHRNA7 |
2 | ALPHA 7 | 561321 | 5% | 38% | 43 | Search ALPHA+7 | Search ALPHA+7 |
3 | ALPHA 7 NICOTINIC RECEPTOR | 478687 | 4% | 36% | 39 | Search ALPHA+7+NICOTINIC+RECEPTOR | Search ALPHA+7+NICOTINIC+RECEPTOR |
4 | ALPHA 7 NICOTINIC ACETYLCHOLINE RECEPTOR | 396715 | 5% | 25% | 47 | Search ALPHA+7+NICOTINIC+ACETYLCHOLINE+RECEPTOR | Search ALPHA+7+NICOTINIC+ACETYLCHOLINE+RECEPTOR |
5 | GTS 21 | 386142 | 2% | 51% | 22 | Search GTS+21 | Search GTS+21 |
6 | ALPHA 7 NACHR | 323235 | 4% | 27% | 35 | Search ALPHA+7+NACHR | Search ALPHA+7+NACHR |
7 | PNU 120596 | 308765 | 1% | 75% | 12 | Search PNU+120596 | Search PNU+120596 |
8 | NICOTINIC RECEPTORS | 262187 | 12% | 7% | 107 | Search NICOTINIC+RECEPTORS | Search NICOTINIC+RECEPTORS |
9 | CHRFAM7A | 228713 | 1% | 67% | 10 | Search CHRFAM7A | Search CHRFAM7A |
10 | ALPHA7 NICOTINIC RECEPTOR | 190591 | 1% | 56% | 10 | Search ALPHA7+NICOTINIC+RECEPTOR | Search ALPHA7+NICOTINIC+RECEPTOR |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | BERTRAND, D , LEE, CHL , FLOOD, D , MARGER, F , DONNELLY-ROBERTS, D , (2015) THERAPEUTIC POTENTIAL OF ALPHA 7 NICOTINIC ACETYLCHOLINE RECEPTORS.PHARMACOLOGICAL REVIEWS. VOL. 67. ISSUE 4. P. 1025 -1073 | 179 | 35% | 10 |
2 | WALLACE, TL , PORTER, RHP , (2011) TARGETING THE NICOTINIC ALPHA7 ACETYLCHOLINE RECEPTOR TO ENHANCE COGNITION IN DISEASE.BIOCHEMICAL PHARMACOLOGY. VOL. 82. ISSUE 8. P. 891-903 | 83 | 53% | 102 |
3 | HASHIMOTO, K , (2015) TARGETING OF ALPHA 7 NICOTINIC ACETYLCHOLINE RECEPTORS IN THE TREATMENT OF SCHIZOPHRENIA AND THE USE OF AUDITORY SENSORY GATING AS A TRANSLATIONAL BIOMARKER.CURRENT PHARMACEUTICAL DESIGN. VOL. 21. ISSUE 26. P. 3797 -3806 | 70 | 56% | 9 |
4 | UTESHEV, VV , (2016) ALLOSTERIC MODULATION OF NICOTINIC ACETYLCHOLINE RECEPTORS: THE CONCEPT AND THERAPEUTIC TRENDS.CURRENT PHARMACEUTICAL DESIGN. VOL. 22. ISSUE 14. P. 1986 -1997 | 95 | 40% | 1 |
5 | THOMSEN, MS , HANSEN, HH , TIMMERMAN, DB , MIKKELSEN, JD , (2010) COGNITIVE IMPROVEMENT BY ACTIVATION OF ALPHA(7) NICOTINIC ACETYLCHOLINE RECEPTORS: FROM ANIMAL MODELS TO HUMAN PATHOPHYSIOLOGY.CURRENT PHARMACEUTICAL DESIGN. VOL. 16. ISSUE 3. P. 323-343 | 96 | 35% | 100 |
6 | CORRADI, J , BOUZAT, C , (2016) UNDERSTANDING THE BASES OF FUNCTION AND MODULATION OF ALPHA 7 NICOTINIC RECEPTORS: IMPLICATIONS FOR DRUG DISCOVERY.MOLECULAR PHARMACOLOGY. VOL. 90. ISSUE 3. P. 288 -299 | 70 | 40% | 4 |
7 | MAZUROV, AA , SPEAKE, JD , YOHANNES, D , (2011) DISCOVERY AND DEVELOPMENT OF ALPHA 7 NICOTINIC ACETYLCHOLINE RECEPTOR MODULATORS.JOURNAL OF MEDICINAL CHEMISTRY. VOL. 54. ISSUE 23. P. 7943 -7961 | 50 | 69% | 30 |
8 | SINKUS, ML , GRAW, S , FREEDMAN, R , ROSS, RG , LESTER, HA , LEONARD, S , (2015) THE HUMAN CHRNA7 AND CHRFAM7A GENES: A REVIEW OF THE GENETICS, REGULATION, AND FUNCTION.NEUROPHARMACOLOGY. VOL. 96. ISSUE . P. 274 -288 | 65 | 36% | 15 |
9 | HAYDAR, SN , DUNLOP, J , (2010) NEURONAL NICOTINIC ACETYLCHOLINE RECEPTORS - TARGETS FOR THE DEVELOPMENT OF DRUGS TO TREAT COGNITIVE IMPAIRMENT ASSOCIATED WITH SCHIZOPHRENIA AND ALZHEIMER'S DISEASE.CURRENT TOPICS IN MEDICINAL CHEMISTRY. VOL. 10. ISSUE 2. P. 144-152 | 40 | 70% | 54 |
10 | HAJOS, M , ROGERS, BN , (2010) TARGETING ALPHA 7 NICOTINIC ACETYLCHOLINE RECEPTORS IN THE TREATMENT OF SCHIZOPHRENIA.CURRENT PHARMACEUTICAL DESIGN. VOL. 16. ISSUE 5. P. 538-554 | 69 | 39% | 50 |
Classes with closest relation at Level 1 |